Behavioral Intention of Receiving Monkeypox Vaccination and Undergoing Monkeypox Testing and the Associated Factors Among Young Men Who Have Sex With Men in China: Large Cross-Sectional Study (Preprint)

Author:

Luo SitongORCID,Jiao KediORCID,Zhang YuhangORCID,Xu YutongORCID,Zhou JingtaoORCID,Huang SiwenORCID,Li YanORCID,Xiao YongkangORCID,Ma WeiORCID,He LinORCID,Ren XianlongORCID,Dai ZhenORCID,Sun JiaruoORCID,Li QingyuORCID,Cheng FengORCID,Liang WannianORCID

Abstract

BACKGROUND

The worldwide human monkeypox (mpox) outbreak in 2022 mainly affected men who have sex with men (MSM). In China, young men who have sex with men (YMSM) were at a potential high risk of mpox infection due to their sexual activeness and the eased COVID-19 restrictions at the end of 2022.

OBJECTIVE

This study aimed to investigate the behavioral intention of receiving mpox vaccination and undergoing mpox testing in 4 different scenarios and explore their associations with background and behavioral theory–related factors among Chinese YMSM.

METHODS

An online cross-sectional survey was conducted among YMSM aged 18-29 years from 6 representative provinces of China in September 2022. Participants recruited (recruitment rate=2918/4342, 67.2%) were asked to self-administer an anonymous questionnaire designed based on prior knowledge about mpox and classic health behavior theories. Data on the participants’ background, mpox knowledge and cognition, mpox vaccination and testing cognition, and the behavioral intention of receiving mpox vaccination and undergoing mpox testing were collected. Descriptive analysis and univariate and multivariate linear regressions were performed. Geodetector was used to measure the stratified heterogeneity of behavioral intention.

RESULTS

A total of 2493 YMSM with a mean age of 24.6 (SD 2.9) years were included. The prevalence of having a behavioral intention of receiving mpox vaccination ranged from 66.2% to 88.4% by scenario, varying in epidemic status and cost. The prevalence of having an mpox testing intention was above 90% in all scenarios regardless of the presence of symptoms and the cost. The positive factors related to vaccination intention included mpox knowledge (b<sub>a</sub>=0.060, 95% CI 0.016-0.103), perceived susceptibility of mpox (b<sub>a</sub>=0.091, 95% CI 0.035-0.146), perceived severity of mpox (b<sub>a</sub>=0.230, 95% CI 0.164-0.296), emotional distress caused by mpox (b<sub>a</sub>=0.270, 95% CI 0.160-0.380), perceived benefits of mpox vaccination (b<sub>a</sub>=0.455, 95% CI 0.411-0.498), self-efficacy of mpox vaccination (b<sub>a</sub>=0.586, 95% CI 0.504-0.668), and having 1 male sex partner (b<sub>a</sub>=0.452, 95% CI 0.098-0.806), while the negative factor was perceived barriers to vaccination (b<sub>a</sub>=–0.056, 95% CI –0.090 to –0.022). The positive factors related to testing intention were perceived severity of mpox (b<sub>a</sub>=0.283, 95% CI 0.241-0.325), perceived benefits of mpox testing (b<sub>a</sub>=0.679, 95% CI 0.636-0.721), self-efficacy of mpox testing (b<sub>a</sub>=0.195, 95% CI 0.146-0.245), having 1 male sex partner (b<sub>a</sub>=0.290, 95% CI 0.070-0.510), and having in-person gatherings with MSM (b<sub>a</sub>=0.219, 95% CI 0.072-0.366), while the negative factor was emotional distress caused by mpox (b<sub>a</sub>=–0.069, 95% CI –0.137 to –0.001).

CONCLUSIONS

Among Chinese YMSM, the intention of undergoing mpox testing is optimal, while the mpox vaccination intention has room for improvement. A future national response should raise YMSM’s mpox knowledge, disseminate updated information about mpox and preventive measures, improve preventive service accessibility and privacy, and provide advice on positively coping with the associated emotional distress.

Publisher

JMIR Publications Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3